QT Imaging Holdings, Inc.
$7
▲
8.44%
2026-04-21 09:02:00
www.qtimaging.com
NCM: QTI
Explore QT Imaging Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$83.45 M
Current Price
$7
52W High / Low
$19.05 / $1.86
Stock P/E
—
Book Value
$0.54
Dividend Yield
—
ROCE
-29.28%
ROE
1363.27%
Face Value
—
EPS
$-2.01
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
31
Beta
-0.09
Debt / Equity
81.36
Current Ratio
2.81
Quick Ratio
2.17
Forward P/E
—
Price / Sales
4.4
Enterprise Value
$78.05 M
EV / EBITDA
-18.12
EV / Revenue
4.12
Rating
None
Target Price
$11.6
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Abbott Laboratories | $93.07 | 25.91 | $162.16 B | 2.6% | 11.47% | 12.96% | $139.06 / $93.92 | $30.02 |
| 2. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 3. | Cytosorbents Corporation | $0.65 | — | $41.24 M | — | -41.3% | -96.39% | $1.39 / $0.5 | $0.09 |
| 4. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 5. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 6. | Intelligent Bio Solutions Inc. | $2.93 | — | $5.86 M | — | -359.62% | -1.5% | $24.9 / $2.42 | $8.96 |
| 7. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 8.28 M | 4.19 M | 3.66 M | 2.8 M | 0.85 M | — |
| Operating Profit | -0.7 M | -1.65 M | -1.04 M | -1.04 M | -2.05 M | — |
| Net Profit | -1.39 M | -4.56 M | -4 M | -11.14 M | 0.18 M | — |
| EPS in Rs | -0.12 | -0.38 | -0.33 | -0.92 | 0.02 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 18.93 M | 4.88 M | 0.04 M | 0 M |
| Operating Profit | -4.44 M | -12.18 M | -5.01 M | -4.28 M |
| Net Profit | -21.08 M | -8.98 M | -6.1 M | -2.77 M |
| EPS in Rs | -1.75 | -0.75 | -0.51 | -0.23 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 23.02 M | 6.09 M | 6.71 M | 41.95 M |
| Total Liabilities | 16.58 M | 15.62 M | 12.02 M | 13.42 M |
| Equity | 6.45 M | -9.54 M | -5.31 M | 28.53 M |
| Current Assets | 22.09 M | 4.92 M | 4.82 M | 0.25 M |
| Current Liabilities | 7.87 M | 9.79 M | 7.34 M | 4.19 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -8.96 M | -10.03 M | -2.65 M | -1.26 M |
| Investing CF | -0.12 M | -0.09 M | -0.01 M | 192.24 M |
| Financing CF | 18.35 M | 11.13 M | 2.37 M | -191.32 M |
| Free CF | -9.08 M | -10.12 M | -2.66 M | -1.26 M |
| Capex | -0.12 M | -0.09 M | -0.01 M | -0.02 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11990.2% | — | — | — |
| Earnings Growth % | -47.32% | -119.84% | — | — |
| Profit Margin % | -184.16% | -15113.25% | — | — |
| Operating Margin % | -249.58% | -12409.76% | — | — |
| Gross Margin % | 54.11% | -234.5% | — | — |
| EBITDA Margin % | -87.56% | -12568.04% | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-10-27 | 1:0.2 |
| 2025-10-24 | 1:0.333333 |